EPCAM and cancer: Combined with the large number of CTCs harvested by negative depletion of WBCs from leukopaks, the multispectral CTC imaging platform will yield a highly quantitative single-cell assessment of epitope expression without biased selection for EpCAM-positive cancer cells.